SIRPA and neoplasm: (171) found that exosomes containing SIRPα could more effectively counteract CD47 on cancer cells, enhancing phagocytosis of tumor cells by macrophages and inhibiting the metastatic growth of tumors, offering a new approach to cancer treatment (Figure 3A).